Sherwood Paula R, Given Barbara A, Scholnik Aaron, Given Charles W
College of Nursing, Michigan State University, East Lansing 48824, USA.
J Cancer Educ. 2004 Spring;19(1):58-65. doi: 10.1207/s15430154jce1901_13.
Despite breakthroughs in experimental cancer treatment, relatively few patients participate in cancer clinical treatment trials (CCTTs). Primary care providers (PCPs) have a strong influence on patients' decisions to participate in a CCTT.
To determine factors that influence PCP referral of patients to CCTTs, we conducted a descriptive survey of 571 Michigan PCPs.
Attendance at CCTT educational sessions consistently predicted referral. Provider attitudes regarding CCTT perceived knowledge, access, and comfort with responsibilities when patients were in a CCTT also predicted referral.
Findings support allocating funds to provide CCTT education to PCPs to increase numbers of patients willing to participate in CCTTs.
尽管实验性癌症治疗取得了突破，但参与癌症临床治疗试验（CCTT）的患者相对较少。初级保健提供者（PCP）对患者参与CCTT的决定有很大影响。
为了确定影响PCP将患者转诊至CCTT的因素，我们对571名密歇根州的PCP进行了描述性调查。
参加CCTT教育课程一直是转诊的预测因素。提供者对CCTT的态度，即当患者参加CCTT时对知识、获取途径以及责任承担的舒适度，也能预测转诊情况。
研究结果支持拨款为PCP提供CCTT教育，以增加愿意参与CCTT的患者数量。
